Protalix BioTherapeutics
PLX
PLX
62 hedge funds and large institutions have $17.2M invested in Protalix BioTherapeutics in 2025 Q2 according to their latest regulatory filings, with 30 funds opening new positions, 19 increasing their positions, 3 reducing their positions, and 30 closing their positions.
Holders
62
Holders Change
-1
Holders Change %
-1.59%
% of All Funds
0.83%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
30
Increased
19
Reduced
3
Closed
30
Calls
$130K
Puts
$58K
Net Calls
+$72K
Net Calls Change
-$600K
Top Buyers
1 |
1
BlackRock
New York
|
$4.99M |
2 |
2
Geode Capital Management
Boston,
Massachusetts
|
$1.22M |
3 |
3
Vanguard Group
Malvern,
Pennsylvania
|
$718K |
4 |
4
State Street
Boston,
Massachusetts
|
$657K |
5 |
5
Renaissance Technologies
New York
|
$2.39M |